UK markets closed

Ekso Bionics Holdings, Inc. (0IFR.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.2355-0.0945 (-7.11%)
At close: 03:11PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.64
52-week change 313.60%
S&P500 52-week change 322.38%
52-week high 33.1000
52-week low 30.0000
50-day moving average 31.9276
200-day moving average 31.6103

Share statistics

Avg vol (3-month) 31.15k
Avg vol (10-day) 31.16k
Shares outstanding 562.64M
Implied shares outstanding 6N/A
Float 815.59M
% held by insiders 113.30%
% held by institutions 16.63%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.066667:1
Last split date 325 Mar 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -19.80%
Operating margin (ttm)-86.69%

Management effectiveness

Return on assets (ttm)-26.34%
Return on equity (ttm)-20.08%

Income statement

Revenue (ttm)17.91M
Revenue per share (ttm)1.20
Quarterly revenue growth (yoy)-8.90%
Gross profit (ttm)N/A
EBITDA -12.21M
Net income avi to common (ttm)-3.55M
Diluted EPS (ttm)-0.9260
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.8M
Total cash per share (mrq)0.5
Total debt (mrq)6.84M
Total debt/equity (mrq)48.69%
Current ratio (mrq)2.81
Book value per share (mrq)0.81

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A